CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,778 | +28.6% | 286,655 | 0.0% | 0.01% | +30.0% |
| Q2 2023 | $421,383 | -24.6% | 286,655 | 0.0% | 0.01% | -33.3% |
| Q1 2023 | $558,977 | -13.3% | 286,655 | 0.0% | 0.02% | -11.8% |
| Q4 2022 | $644,974 | -6.7% | 286,655 | 0.0% | 0.02% | -10.5% |
| Q3 2022 | $691,000 | +16.1% | 286,655 | 0.0% | 0.02% | +35.7% |
| Q2 2022 | $595,000 | -26.4% | 286,655 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $808,000 | -26.7% | 286,655 | +21.3% | 0.02% | -20.0% |
| Q4 2021 | $1,103,000 | +153.6% | 236,255 | +46.8% | 0.02% | +150.0% |
| Q3 2021 | $435,000 | -0.2% | 160,987 | +5.0% | 0.01% | 0.0% |
| Q2 2021 | $436,000 | -7.8% | 153,387 | -1.8% | 0.01% | -11.1% |
| Q1 2021 | $473,000 | +6.3% | 156,187 | +3.2% | 0.01% | 0.0% |
| Q4 2020 | $445,000 | -24.2% | 151,287 | -17.3% | 0.01% | -30.8% |
| Q3 2020 | $587,000 | -3.6% | 183,000 | 0.0% | 0.01% | +8.3% |
| Q2 2020 | $609,000 | -8.3% | 183,000 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $664,000 | -29.5% | 183,000 | 0.0% | 0.02% | +15.4% |
| Q4 2019 | $942,000 | -13.2% | 183,000 | 0.0% | 0.01% | -13.3% |
| Q3 2019 | $1,085,000 | -6.9% | 183,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $1,166,000 | +0.2% | 183,000 | -8.7% | 0.02% | +7.1% |
| Q1 2019 | $1,164,000 | -7.8% | 200,400 | 0.0% | 0.01% | -17.6% |
| Q4 2018 | $1,263,000 | +7.7% | 200,400 | -2.4% | 0.02% | +54.5% |
| Q3 2018 | $1,173,000 | -6.8% | 205,400 | 0.0% | 0.01% | -15.4% |
| Q2 2018 | $1,259,000 | -33.6% | 205,400 | -27.6% | 0.01% | -35.0% |
| Q1 2018 | $1,895,000 | -10.0% | 283,700 | 0.0% | 0.02% | -13.0% |
| Q4 2017 | $2,105,000 | +5.1% | 283,700 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $2,003,000 | -3.5% | 283,700 | -3.4% | 0.02% | -8.0% |
| Q2 2017 | $2,076,000 | +1.9% | 293,700 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $2,038,000 | +33.6% | 293,700 | +5.9% | 0.02% | +25.0% |
| Q4 2016 | $1,525,000 | +9.8% | 277,300 | 0.0% | 0.02% | -4.8% |
| Q3 2016 | $1,389,000 | +11.3% | 277,300 | 0.0% | 0.02% | +10.5% |
| Q2 2016 | $1,248,000 | +0.2% | 277,300 | 0.0% | 0.02% | -9.5% |
| Q1 2016 | $1,245,000 | +85.8% | 277,300 | +117.8% | 0.02% | +75.0% |
| Q4 2015 | $670,000 | +38.1% | 127,300 | +51.5% | 0.01% | +20.0% |
| Q3 2015 | $485,000 | -19.3% | 84,000 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $601,000 | +7.5% | 84,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $559,000 | +10.9% | 84,000 | 0.0% | 0.01% | +9.1% |
| Q4 2014 | $504,000 | +21.4% | 84,000 | 0.0% | 0.01% | +10.0% |
| Q3 2014 | $415,000 | +9.8% | 84,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $378,000 | 0.0% | 84,000 | 0.0% | 0.01% | -9.1% |
| Q1 2014 | $378,000 | -11.9% | 84,000 | 0.0% | 0.01% | -15.4% |
| Q4 2013 | $429,000 | +12.6% | 84,000 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $381,000 | +353.6% | 84,000 | +409.1% | 0.01% | +333.3% |
| Q2 2013 | $84,000 | – | 16,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |